In contrast, copy number analysis of her DIPG revealed copy number changes frequently seen in gliomas including homozygous loss of RB1, SETDB2, CDKN2A and CDKN2B with no abnormalities in chromosome 17, distinguishing it from the primary medulloblastoma (Fig. 3d-e). This evidence concerns the gene SETDB2 and central nervous system cancer.